Networks
Clinical Studies (1)
- Leppert : Study aims to evaluate the efficacy and safety of Temelimab as a treatment for post COVID-19 syndrome neuropsychiatric symptoms in patients who had severe acute SARS-CoV-2 infection but did not undergo intensive care treatment during the acute period
External Links
Other information
If you would like to contact the site, please email: ccb@ateneo.univr.it
The data is updated up to